UroGen Pharma
URGN
URGN
65 hedge funds and large institutions have $116M invested in UroGen Pharma in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1% more capital invested
Capital invested by funds: $115M → $116M (+$625K)
2.98% less ownership
Funds ownership: 56.4% → 53.41% (-3%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
65
Holding in Top 10
–
Calls
$875K
Puts
$106K
Top Buyers
| 1 | +$1.48M | |
| 2 | +$871K | |
| 3 | +$784K | |
| 4 |
Millennium Management
New York
|
+$716K |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$682K |
Top Sellers
| 1 | -$5.58M | |
| 2 | -$4.81M | |
| 3 | -$598K | |
| 4 |
WCM
Wildcat Capital Management
New York
|
-$347K |
| 5 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$346K |